Regeneron Pharmaceuticals, Inc. SEC filings REGN
Regeneron Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 13, 2017. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| N-PX | Filing | Aug 20, 2026 | Jun 30, 2026 |
| UPLOAD | Letter from the SEC | Apr 17, 2025 | — |
| CORRESP | Letter to the SEC | Apr 3, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2024 | — |
| CORRESP | Letter to the SEC | Aug 1, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| CORRESP | Letter to the SEC | May 20, 2024 | — |
| UPLOAD | Letter from the SEC | May 9, 2024 | — |
| SC TO-T/A | Filing | Sep 25, 2023 | — |
| SC TO-T/A | Filing | Sep 12, 2023 | — |
| SC TO-T/A | Filing | Sep 8, 2023 | — |
| SC TO-T | Filing | Aug 25, 2023 | — |
| SC TO-C | Filing | Aug 9, 2023 | — |
| PX14A6G | Filing | May 18, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2022 | — |
| CORRESP | Letter to the SEC | Oct 7, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| SC TO-T/A | Filing | May 31, 2022 | — |
| SC TO-T/A | Filing | May 20, 2022 | — |
| SC TO-T/A | Filing | May 11, 2022 | — |
| SC TO-T | Filing | May 2, 2022 | — |
| SC TO-C | Sc to-t | Apr 19, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2021 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2020 | — |
| CT ORDER | Filing | Jul 15, 2020 | — |
| CT ORDER | Filing | Oct 8, 2019 | — |
| CT ORDER | Filing | May 14, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| CT ORDER | Filing | Jul 26, 2018 | — |
| CT ORDER | Filing | Jan 9, 2018 | — |
| CT ORDER | Filing | Dec 7, 2017 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- REGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Tarrytown, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 872589
- Former names
- REGENERON PHARMACEUTICALS INC (until Jun 19, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.